Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Digestion. 2022;103(5):367-377. doi: 10.1159/000525314. Epub 2022 Jun 30.
BACKGROUND/AIMS: Although most patients with presumptive colonic diverticular bleeding (CDB) do not undergo a small bowel investigation in clinical practice, no prospective study supports this management. We evaluated the utility of early small bowel capsule endoscopy (CE) after negative colonoscopy results.
This prospective study evaluated the diagnostic yield of early small bowel CE (≤3 days from visit) for consecutive patients with acute-onset hematochezia, when colonoscopy found colonic diverticulosis but did not identify the definite bleeding source (n = 51; presumptive CDB). As a matched control for comparing clinical outcomes, presumptive CDB patients without CE (n = 51) were retrospectively extracted.
On CE for the prospective cohort, the rates of total positive findings, P2 findings (high bleeding potential according to the P classification), and blood pooling in the colon were 57%, 12% (ulceration, 8%; angioectasia, 4%), and 24%, respectively. The rates of rebleeding within 30 and 365 days were 16% and 29% in the prospective cohort with CE, respectively, and were not significantly different from those in the retrospective cohort without CE (10% and 25%, respectively). In addition, thromboembolism and mortality within 30 and 365 days were not significantly different between those with and without CE.
Early CE detected a suspected small bowel bleeding source in 12% of acute-onset presumptive CDB patients but did not significantly improve major clinical outcomes. Therefore, routine CE is unnecessary for presumptive CDB patients after colonoscopy (UMIN000026676).
背景/目的:尽管大多数疑似结肠憩室出血(CDB)患者在临床实践中无需进行小肠检查,但尚无前瞻性研究支持这种治疗方法。我们评估了阴性结肠镜检查后早期小肠胶囊内镜(CE)的诊断价值。
这项前瞻性研究评估了早期小肠 CE(就诊后≤3 天)对急性便血且结肠镜检查发现结肠憩室病但未确定明确出血源的连续患者(n=51;疑似 CDB)的诊断效果。作为比较临床结果的匹配对照,回顾性提取了疑似 CDB 且未进行 CE 的患者(n=51)。
前瞻性队列中 CE 的总阳性发现率、P2 发现率(根据 P 分类具有高出血风险)和结肠积血率分别为 57%、12%(溃疡 8%;血管扩张 4%)和 24%。CE 前瞻性队列中 30 天和 365 天内再出血率分别为 16%和 29%,与无 CE 的回顾性队列(分别为 10%和 25%)相比,无显著差异。此外,30 天和 365 天内血栓栓塞和死亡率在有和无 CE 的患者之间也无显著差异。
早期 CE 检测到 12%的急性疑似 CDB 患者存在疑似小肠出血源,但并未显著改善主要临床结局。因此,结肠镜检查后疑似 CDB 患者无需常规进行 CE(UMIN000026676)。